| abstract |
The invention provides formula compounds where R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for its preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are microsomal prostaglandin E synthase-1 inhibitors. |